Sou Hu Cai Jing·2025-06-19 16:42Group 1 - The core point of the news is that the Huatai Fuhua Medical Service Flexible Allocation Mixed C fund has experienced a decline of 1.56% on June 19, with a cumulative drop of 9.38% over five consecutive trading days, and its latest net value is 1.64 yuan [1] - The fund was established in February 2022, with a total scale of 346 million yuan, and has recorded a cumulative return of -3.47% since inception [1] - As of the end of 2024, institutional investors hold 250 million shares of the fund, accounting for 97.27% of the total shares, while individual investors hold 7 million shares, accounting for 2.73% [1] Group 2 - The current fund manager, Ms. Zhang Wei, has a background in biomedical studies from Cornell University and has held various positions in the pharmaceutical research field before managing multiple funds since 2021 [2] - As of March 31, 2025, the top ten holdings of the Huatai Fuhua Medical Service Flexible Allocation Mixed C fund account for a total of 64.17%, with significant investments in companies such as Heng Rui Pharmaceutical (10.23%) and Ke Long Pharmaceutical (9.09%) [2]